November 11th 2024
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.
Characterization of Product Related Variants in Therapeutic mAbs
October 15th 2024Navin Rauniyar and Xuemei Han of Tanvex Biopharma USA recently discussed how identifying product-related variants through characterization enables the recognition of impurities that compromise the quality and safety of drugs.
Separation Science — The State Of The Art in Life Science Analysis: A Virtual Symposium
September 26th 2024Webinar Date/Time: Wednesday, October 23rd, 2024 Morning Session: 14:30 pm BST | 9:30 am EDT | 15:30 pm CEST Afternoon Session: 16:30 pm BST | 11:30 am EDT | 17:30 pm CEST Thursday, October 24th, 2024 Morning Session: 14:30 pm BST | 9:30 am EDT | 15:30 pm CEST Afternoon Session: 16:10 pm BST | 11:10 am EDT | 17:10 pm CEST
Rapid Quantitative Analysis of Ethylene Oxide and 1,4-Dioxane in Polymeric Excipients Using SIFT-MS
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.